DeWeese, T L <br/><br/>
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.  [electronic resource] 

 -  Cancer research  Oct 2001 
 - 7464-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--immunology<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Viral--blood<br/>Biopsy<br/>Humans<br/>Injections, Intralesional<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--radiotherapy<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--radiotherapy